Loading page content…
Loading page content…
The Medicines Discovery Institute (MDI) requires a 24-well high-density microelectrode array (HD-MEA) system to measure how drug candidates affect electrical activity in living human neuronal cultures. Researchers will use the array to record activity from individual neurons, track signal propagation along their axons over time, stimulate selected sites and compare responses across multiple wells in parallel. Following market research into this equipment and it's intended uses, we currently believe there are no suitable alternatives available capable of performing to our required standards. In addition to this, since the last notice posted (UK5), we have been made aware that the grant funding award letter mandates the purchase of specific, branded equipment, and therefore we will continue with this award to our preferred (and mandated), supplier.
Create a free account to read the full notice and search for similar work. When you need help writing and reviewing a bid, you can choose a paid plan. No card needed to start searching.
Continue with this notice →